ラクオリア創薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/11/18 | 1,375 | 1,400 | 1,304 | 1,385 | +155 | +12.6% | 1,971,900 |
2022/11/17 | 1,266 | 1,274 | 1,221 | 1,230 | -51 | -4% | 282,300 |
2022/11/16 | 1,290 | 1,305 | 1,269 | 1,281 | -11 | -0.9% | 291,700 |
2022/11/15 | 1,236 | 1,295 | 1,228 | 1,292 | +56 | +4.5% | 494,000 |
2022/11/14 | 1,125 | 1,258 | 1,118 | 1,236 | +126 | +11.4% | 911,400 |
2022/11/11 | 1,126 | 1,129 | 1,102 | 1,110 | -8 | -0.7% | 139,700 |
2022/11/10 | 1,108 | 1,119 | 1,100 | 1,118 | -4 | -0.4% | 89,900 |
2022/11/09 | 1,111 | 1,125 | 1,107 | 1,122 | +11 | +1% | 62,000 |
2022/11/08 | 1,114 | 1,129 | 1,110 | 1,111 | +4 | +0.4% | 70,900 |
2022/11/07 | 1,119 | 1,119 | 1,098 | 1,107 | -15 | -1.3% | 100,000 |
2022/11/04 | 1,122 | 1,137 | 1,120 | 1,122 | -16 | -1.4% | 91,300 |
2022/11/02 | 1,141 | 1,142 | 1,129 | 1,138 | -10 | -0.9% | 70,200 |
2022/11/01 | 1,157 | 1,182 | 1,140 | 1,148 | ±0 | ±0% | 114,800 |
2022/10/31 | 1,166 | 1,171 | 1,148 | 1,148 | -11 | -0.9% | 93,400 |
2022/10/28 | 1,140 | 1,168 | 1,140 | 1,159 | +4 | +0.3% | 89,300 |
2022/10/27 | 1,114 | 1,166 | 1,114 | 1,155 | +43 | +3.9% | 229,800 |
2022/10/26 | 1,116 | 1,135 | 1,106 | 1,112 | ±0 | ±0% | 123,600 |
2022/10/25 | 1,110 | 1,122 | 1,102 | 1,112 | +2 | +0.2% | 100,300 |
2022/10/24 | 1,122 | 1,128 | 1,091 | 1,110 | ±0 | ±0% | 160,800 |
2022/10/21 | 1,140 | 1,140 | 1,098 | 1,110 | -49 | -4.2% | 296,600 |
2022/10/20 | 1,085 | 1,245 | 1,070 | 1,159 | +61 | +5.6% | 1,851,700 |
2022/10/19 | 1,106 | 1,116 | 1,090 | 1,098 | -13 | -1.2% | 91,800 |
2022/10/18 | 1,076 | 1,115 | 1,076 | 1,111 | +29 | +2.7% | 173,800 |
2022/10/17 | 1,064 | 1,082 | 1,063 | 1,082 | +4 | +0.4% | 67,600 |
2022/10/14 | 1,066 | 1,094 | 1,060 | 1,078 | +22 | +2.1% | 133,200 |
2022/10/13 | 1,080 | 1,080 | 1,051 | 1,056 | -18 | -1.7% | 99,100 |
2022/10/12 | 1,071 | 1,080 | 1,066 | 1,074 | +3 | +0.3% | 92,500 |
2022/10/11 | 1,073 | 1,082 | 1,067 | 1,071 | -17 | -1.6% | 65,300 |
2022/10/07 | 1,070 | 1,098 | 1,065 | 1,088 | +10 | +0.9% | 72,400 |
2022/10/06 | 1,082 | 1,086 | 1,074 | 1,078 | +8 | +0.7% | 44,400 |
2022/10/05 | 1,069 | 1,081 | 1,063 | 1,070 | +9 | +0.8% | 61,100 |
2022/10/04 | 1,062 | 1,068 | 1,054 | 1,061 | +17 | +1.6% | 78,000 |
2022/10/03 | 1,029 | 1,050 | 1,015 | 1,044 | ±0 | ±0% | 52,200 |
2022/09/30 | 1,034 | 1,054 | 1,030 | 1,044 | -2 | -0.2% | 73,300 |
2022/09/29 | 1,036 | 1,060 | 1,028 | 1,046 | +35 | +3.5% | 77,300 |
2022/09/28 | 1,029 | 1,048 | 1,007 | 1,011 | -19 | -1.8% | 102,000 |
2022/09/27 | 1,014 | 1,041 | 1,007 | 1,030 | +24 | +2.4% | 108,000 |
2022/09/26 | 1,009 | 1,033 | 1,005 | 1,006 | -28 | -2.7% | 118,700 |
2022/09/22 | 1,000 | 1,044 | 999 | 1,034 | +21 | +2.1% | 131,500 |
2022/09/21 | 1,030 | 1,035 | 1,002 | 1,013 | -33 | -3.2% | 170,100 |
2022/09/20 | 1,084 | 1,085 | 1,036 | 1,046 | -39 | -3.6% | 216,000 |
2022/09/16 | 1,095 | 1,099 | 1,076 | 1,085 | -26 | -2.3% | 172,600 |
2022/09/15 | 1,135 | 1,135 | 1,109 | 1,111 | -12 | -1.1% | 120,000 |
2022/09/14 | 1,120 | 1,153 | 1,119 | 1,123 | -32 | -2.8% | 237,500 |
2022/09/13 | 1,149 | 1,163 | 1,138 | 1,155 | +10 | +0.9% | 136,600 |
2022/09/12 | 1,149 | 1,153 | 1,131 | 1,145 | +1 | +0.1% | 159,300 |
2022/09/09 | 1,099 | 1,157 | 1,098 | 1,144 | +51 | +4.7% | 338,900 |
2022/09/08 | 1,114 | 1,114 | 1,081 | 1,093 | +8 | +0.7% | 132,600 |
2022/09/07 | 1,116 | 1,116 | 1,075 | 1,085 | -28 | -2.5% | 155,000 |
2022/09/06 | 1,078 | 1,131 | 1,073 | 1,113 | +39 | +3.6% | 224,900 |
601~
650
件表示中 / 3374件
類似銘柄と比較する
現在ご覧いただいている「ラクオリア」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ラクオリア | 41,800円 | +25.1% | - | 0.00% | - | 1.84倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
メディシノバ | 21,700円 | - | - | - | - | - |
|
- |
坪田ラボ | 41,100円 | +100.6% | - | 0.00% | 52.69倍 | 7.46倍 |
|
近視進行抑制、脳活性化などに強いバイオベンチャー。企業との早期契約による収益化で実績 |
NANO | 13,300円 | -20.0% | - | 0.00% | - | 3.09倍 |
|
mRNA医薬品に特化した創薬ベンチャー。創薬シーズ発掘から非臨床開発まで手がけて導出 |
カイオム | 13,400円 | +92.3% | - | 0.00% | - | 4.75倍 |
|
独自の抗体作製技術を持つ理研発の創薬ベンチャー。医薬品候補抗体導出と技術供与が収益源 |
市場注目の銘柄
チャート関連のコラム